title: Cost of treatment failure for major depression: direct costs of continued treatment.
abstract: Understanding subsequent costs of treating patients who fail initial treatment for depression is critical in cost-effectiveness analysis. This prospective observational study calculated such costs in a community mental health center. Total mean annual direct per-patient costs were $6,818 to $8,661. This total was markedly higher than those reported in studies that were based partially on the assumptions of expert panels rather than observed utilization rates. These results suggest that in settings similar to the present study, antidepressant treatments with higher failure rates may carry a marked hidden cost disadvantage.
authors.affiliation: Yale School of Medicine, Department of Psychiatry, Connecticut Mental Health Center, USA. Bruce.Baker@Yale.Edu
authors.forename: C B
authors.initials: CB
authors.lastname: Baker
authors.forename: S W
authors.initials: SW
authors.lastname: Woods
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D003155:Community Mental Health Centers / Q000191:economics*; D003866:Depressive Disorder / Q000188:drug therapy / Q000191:economics*; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006801:Humans; D018803:Models, Economic; D010343:Patient Admission / Q000191:economics; D011446:Prospective Studies; D017211:Treatment Failure; D014600:Utilization Review
chemical_list: D000928:Antidepressive Agents